Evidence map›Paper›PMID 25088215›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2014

Mutual amplification of corticosteroids and angiotensin systems in human vascular smooth muscle cells and carotid atheroma.

Hanène Ayari, Liliana Legedz, Catherine Cerutti, Pierre Lantelme, Patrick Feugier, Marie-Paule Gustin, Olivier Lohez, Ali Nehme, Jacques Yuan Li, Jouda Gharbi-Chihi and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Effect of Pituitary-Target Gland Axis on RAAS in the Context of COVID-19.International journal of medical sciences · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Efficiency and specificity of RAAS inhibitors in cardiovascular diseases: how to achieve better end-organ protection?Hypertension research : official journal of the Japanese Society of Hypertension · 2017
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Hanène AyariHôpital Nord Ouest, Villefranche, Université Lyon1, INSERM, ERI22, 8 Avenue Rockefeller, EA 4173, Lyon, France.
Liliana LegedzHôpital Nord Ouest, Villefranche, Université Lyon1, INSERM, ERI22, 8 Avenue Rockefeller, EA 4173, Lyon, France.
Catherine CeruttiHôpital Nord Ouest, Villefranche, Université Lyon1, INSERM, ERI22, 8 Avenue Rockefeller, EA 4173, Lyon, France.
Pierre LantelmeHôpital Nord Ouest, Villefranche, Université Lyon1, INSERM, ERI22, 8 Avenue Rockefeller, EA 4173, Lyon, France.
Patrick FeugierHôpital Nord Ouest, Villefranche, Université Lyon1, INSERM, ERI22, 8 Avenue Rockefeller, EA 4173, Lyon, France.
Marie-Paule GustinHôpital Nord Ouest, Villefranche, Université Lyon1, INSERM, ERI22, 8 Avenue Rockefeller, EA 4173, Lyon, France.
Olivier LohezHôpital Nord Ouest, Villefranche, Université Lyon1, INSERM, ERI22, 8 Avenue Rockefeller, EA 4173, Lyon, France.
Ali NehmeHôpital Nord Ouest, Villefranche, Université Lyon1, INSERM, ERI22, 8 Avenue Rockefeller, EA 4173, Lyon, France.
Jacques Yuan LiHôpital Nord Ouest, Villefranche, Université Lyon1, INSERM, ERI22, 8 Avenue Rockefeller, EA 4173, Lyon, France.
Jouda Gharbi-ChihiFaculté de Médecine de Tunis, Laboratoire de Biochimie, Tunis, Tunisia.
Giampiero BriccaHôpital Nord Ouest, Villefranche, Université Lyon1, INSERM, ERI22, 8 Avenue Rockefeller, EA 4173, Lyon, France. giampiero.bricca@inserm.fr.
Université Claude Bernard Lyon 1 · FRHôpital Nord · FRInserm · FRTunis University · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledThe involvement of the renin-angiotensin-aldosterone system (RAAS) and cortisol in increased cardiovascular risk is well known. If numerous relationships between RAAS and corticosteroids have been described, their interactions within the arterial wall, especially during the transdifferentiation of vascular smooth muscle cells (VSMCs) and the atheroma formation, are not established. Here, we clarified the relationships between mRNA levels of corticosteroid and angiotensin system components using cortisol, fludrocortisone, and angiotensin II treatments of cultured VSMCs maintained in a contractile phenotype or induced to a lipid storing phenotype. We then determined the quantitative relationships between the mRNA content of these components measured with reverse transcription polymerase chain reaction (RT-PCR), in the atheroma plaque and nearby macroscopically intact tissue (MIT) from 27 human carotid endarterectomy samples. In both VSMC phenotypes, cortisol markedly increased both angiotensinogen (AGT) and AT1-receptor (AT1R) mRNA levels. These effects of cortisol were mediated via glucocorticoid receptor-α (GRα) without any illicit activation of the mineralocorticoid receptor (MR). Angiotensin II increased GRα, 11βHSD1, CYP11B1, as well as CYP11B2 mRNAs and decreased AT1R in contractile VSMC; only GRα and CYP11B2 were increased in lipid storing VSMCs, while MR and AGT mRNAs decreased. In endarterectomy specimens, positive correlations between mRNA levels of AGT and aldosterone synthase or 11βHSD1 in MIT and of AT1R and MR in atheroma were detected. The arterial tissue angiotensin system is a target for local glucocorticoids and arterial glucocorticoids for angiotensin II. Both systems appear activated in lipid storing VSMCs and strongly correlated in vivo, and their mutual amplification may contribute to the development of atheroma. KEY MESSAGE: Cortisol increases angiotensin II signaling in VSMCs via GRα. Angiotensin II stimulates cortisol signaling through increased GRα and 11β-HSD1. Corticoid and angiotensin receptors are strongly correlated in the arterial wall. These correlations are maintained at different stages of atheroma development. An auto-amplification loop between angiotensin and cortisol signaling favors atherogenesis.

Indexed as

Adrenal Cortex HormonesAgedAngiotensin IIAngiotensinsCarotid ArteriesCell DifferentiationCell TransdifferentiationFludrocortisoneHumansHydrocortisoneLipidsMuscle ContractionMuscle, Smooth, VascularMyocytes, Smooth MusclePhenotypePlaque, AtheroscleroticAdrenal Cortex HormonesAngiotensin IIAngiotensinsFludrocortisoneHydrocortisoneLipidsReceptors, MineralocorticoidAdipocyteAngiotensinArteryAtherosclerosisGlucocorticoidsLipid storageMineralocorticoidsNuclear receptorsTransdifferentiationType 2 diabetes

Identifiers

PMID25088215
OpenAlexW1972026747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.